Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB – IIIA Non‐Small‐Cell Lung Cancer: Phase 2 neoSCORE Trial

Cancer Science · Published 2026-06-07 · DOI 10.1111/cas.70442

Free full text

Authors (14)

Miner Shao, Jie Yao, Lufeng Zhao, Ling Zhu, Baizhou Li, Lili Li, Bangyi Zhou, Yixin Zhang, Huiying Liu, Xiaoke Chen, Zuqun Wu, Zexin Chen, Junqiang Fan, Fuming Qiu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shao, M., Yao, J., Zhao, L., et al. (2026). Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB – IIIA Non‐Small‐Cell Lung Cancer: Phase 2 neoSCORE Trial. Cancer Science. https://doi.org/10.1111/cas.70442

Related articles